Dysphagia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update

Dysphagia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update

Summary

This reports provides a data-driven overview of the current and future competitive landscape in Dysphagia therapeutics.

Synopsis

In 2022, there will be more than 182 million diagnosed prevalent cases of dysphagia across 16 pharmaceutical markets.

There is no US FDA approved marketed product for the treatment of dysphagia.

R&D activity in dysphagia is minimal, with only two products being developed in the current pipeline.

Non-industrial sponsors dominate clinical trial development in dysphagia, with the US emerging as the key country for conducting trials in dysphagia.

Deals involving asset transaction are the most common types of deal globally.

No new regulatory filings or approvals are expected in the next 18 months.

Scope

GlobalData’s Dysphagia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include -

Disease Landscape

Disease Overview

Epidemiology Overview

Treatment Overview

Marketed Products Assessment

Breakdown by Mechanism of Action, Molecule Type and Route of Administration

Pipeline Assessment

Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration

Late-to-mid-stage Pipeline Drugs

Clinical Trials Assessment

Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status

Enrolment Analytics, Site Analytics, Feasibility Analysis

Deals Landscape

Mergers, Acquisitions, and Strategic Alliances by Region

Overview of Recent Deals

Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the Dysphagia market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Dysphagia market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.